Merck KGaA Stock

Equities

MRK

DE0006599905

Pharmaceuticals

Real-time Estimate Tradegate 10:48:15 2024-04-18 am EDT 5-day change 1st Jan Change
146.4 EUR -0.54% Intraday chart for Merck KGaA -3.39% +1.80%
Sales 2024 * 21.25B 22.68B Sales 2025 * 22.5B 24.01B Capitalization 64B 68.3B
Net income 2024 * 2.97B 3.17B Net income 2025 * 3.48B 3.71B EV / Sales 2024 * 3.33 x
Net Debt 2024 * 6.79B 7.25B Net Debt 2025 * 4.83B 5.16B EV / Sales 2025 * 3.06 x
P/E ratio 2024 *
21.6 x
P/E ratio 2025 *
18.3 x
Employees 62,908
Yield 2024 *
1.57%
Yield 2025 *
1.64%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.49%
1 week-4.28%
Current month-11.16%
1 month-7.07%
3 months-0.92%
6 months-0.14%
Current year+0.87%
More quotes
1 week
142.70
Extreme 142.7
155.20
1 month
142.70
Extreme 142.7
164.85
Current year
140.50
Extreme 140.5
164.85
1 year
134.30
Extreme 134.3
172.40
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
58.00
Extreme 58
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 53 19-04-25
Members of the board TitleAgeSince
Director/Board Member - -
Chairman 67 19-04-25
Director/Board Member 62 90-12-31
More insiders
Date Price Change Volume
24-04-18 146.6 -0.41% 345 730
24-04-17 147.2 -2.58% 370,848
24-04-16 151.1 -0.72% 314,738
24-04-15 152.2 -0.91% 160,741
24-04-12 153.6 +1.15% 227,660

Delayed Quote Xetra, April 18, 2024 at 06:26 am EDT

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
147.2 EUR
Average target price
182 EUR
Spread / Average Target
+23.64%
Consensus